派林生物
(000403)
| 流通市值：145.23亿 | | | 总市值：155.06亿 |
| 流通股本：6.85亿 | | | 总股本：7.31亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 754,186,603.94 | 850,349,304.1 | 988,509,109.12 | 1,429,349,951.47 |
| 应收票据及应收账款 | 579,108,848.4 | 519,268,700.61 | 489,142,598.9 | 592,767,056.19 |
| 其中：应收票据 | 7,932,995.11 | 5,755,681.11 | 3,438,141.3 | 9,188,308.99 |
| 应收账款 | 571,175,853.29 | 513,513,019.5 | 485,704,457.6 | 583,578,747.2 |
| 应收款项融资 | 13,203,838.86 | 14,445,934.66 | 21,563,043.87 | 26,739,935.61 |
| 预付款项 | 46,060,757.91 | 21,832,161.84 | 46,039,364.41 | 26,735,906 |
| 其他应收款合计 | 8,372,736.88 | 13,586,580.3 | 18,426,035.07 | 15,600,822.32 |
| 其中:应收利息 | 1,479,452.05 | 1,479,452.05 | 2,005,424.87 | 2,515,068.47 |
| 存货 | 1,139,194,714.69 | 1,139,640,065.04 | 1,104,864,882.11 | 909,374,530.76 |
| 其他流动资产 | 1,990,316.21 | 7,241,621.68 | 2,692,312.53 | 2,169,313.13 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,542,327,499.32 | 3,419,669,292.38 | 3,441,910,520.51 | 3,426,074,653.6 |
| 非流动资产: | | | | |
| 长期应收款 | 600,000,000 | 600,000,000 | 600,000,000 | 600,000,000 |
| 投资性房地产 | 311,874.23 | 318,994.19 | 326,114.15 | 333,234.11 |
| 固定资产 | 1,373,956,195.97 | 1,066,897,008.9 | 993,051,782.99 | 942,994,319.65 |
| 在建工程 | 463,311,557.62 | 670,464,323.37 | 619,434,853.94 | 582,699,721.94 |
| 使用权资产 | 25,006,305.98 | 26,380,198.93 | 22,987,615.44 | 28,117,536.78 |
| 无形资产 | 203,906,755.23 | 208,912,472.36 | 212,698,475.5 | 212,593,054.84 |
| 开发支出 | 92,103,597.55 | 77,952,200.48 | 73,015,743.34 | 67,642,803.63 |
| 商誉 | 2,614,611,614.12 | 2,614,611,614.12 | 2,614,611,614.12 | 2,614,611,614.12 |
| 长期待摊费用 | 9,443,653.11 | 10,414,211.28 | 11,204,803.26 | 11,829,793.3 |
| 递延所得税资产 | 41,043,900.39 | 39,857,692.88 | 43,126,803.96 | 49,036,126.15 |
| 其他非流动资产 | 87,193,349.45 | 101,199,249.14 | 85,438,625.74 | 94,541,226.41 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,510,888,803.65 | 5,417,007,965.65 | 5,275,896,432.44 | 5,204,399,430.93 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,053,216,302.97 | 8,836,677,258.03 | 8,717,806,952.95 | 8,630,474,084.53 |
| 流动负债: | | | | |
| 短期借款 | 265,698,040.33 | 249,161,048.96 | 275,870,857.11 | 250,571,441.88 |
| 交易性金融负债 | - | 29,125,658.05 | 29,125,658.05 | 29,125,658.05 |
| 应付票据及应付账款 | 178,491,158.71 | 227,295,153.03 | 158,135,531.31 | 154,347,117.16 |
| 应付账款 | 178,491,158.71 | 227,295,153.03 | 158,135,531.31 | 154,347,117.16 |
| 合同负债 | 9,684,977.64 | 27,152,147 | 16,543,720.51 | 10,763,491.83 |
| 应付职工薪酬 | 31,492,784.63 | 37,162,446.71 | 26,941,727.41 | 59,542,747.97 |
| 应交税费 | 54,976,186.36 | 42,919,434.49 | 41,772,560.2 | 71,054,040.07 |
| 其他应付款合计 | 288,087,246.09 | 264,715,022.26 | 284,956,456.67 | 311,379,686.18 |
| 应付股利 | 1,007,905.37 | 849,568.02 | 495,732.4 | 495,732.4 |
| 一年内到期的非流动负债 | 37,219,818.8 | 39,930,140.6 | 24,525,821.28 | 27,891,714.2 |
| 其他流动负债 | 5,806,402.28 | 2,712,941.04 | 1,223,054.36 | 7,518,668.04 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 871,456,614.84 | 920,173,992.14 | 859,095,386.9 | 922,194,565.38 |
| 非流动负债: | | | | |
| 长期借款 | 271,227,337.53 | 222,545,337.53 | 227,754,086.62 | 196,079,086.62 |
| 租赁负债 | 22,034,052.35 | 20,327,754.68 | 19,833,619.93 | 21,477,416.85 |
| 长期应付款 | 9,000,000 | 9,000,000 | 9,000,000 | 9,000,000 |
| 递延收益 | 33,479,292.75 | 34,217,852.58 | 34,771,970.41 | 35,603,377.39 |
| 递延所得税负债 | 21,192,151.77 | 21,359,022.96 | 22,801,747.28 | 24,255,756.49 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 356,932,834.4 | 307,449,967.75 | 314,161,424.24 | 286,415,637.35 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,228,389,449.24 | 1,227,623,959.89 | 1,173,256,811.14 | 1,208,610,202.73 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 733,043,291 | 733,043,291 | 732,786,558 | 733,000,702 |
| 资本公积 | 4,796,355,404.07 | 4,796,355,404.07 | 4,791,053,867.52 | 4,792,964,550.84 |
| 减:库存股 | 40,108,519.91 | 40,108,519.91 | 40,108,519.91 | 43,172,950.37 |
| 其他综合收益 | 40,943.34 | 50,043.65 | 47,597.45 | 46,583.25 |
| 盈余公积 | 133,435,422.24 | 133,435,422.24 | 110,197,995.72 | 110,197,995.72 |
| 未分配利润 | 2,208,944,306.43 | 1,993,195,756.29 | 1,957,561,003.47 | 1,835,612,376.62 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,831,710,847.17 | 7,615,971,397.34 | 7,551,538,502.25 | 7,428,649,258.06 |
| 少数股东权益 | -6,883,993.44 | -6,918,099.2 | -6,988,360.44 | -6,785,376.26 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,824,826,853.73 | 7,609,053,298.14 | 7,544,550,141.81 | 7,421,863,881.8 |
| 负债和股东权益合计 | 9,053,216,302.97 | 8,836,677,258.03 | 8,717,806,952.95 | 8,630,474,084.53 |
| 公告日期 | 2024-10-28 | 2024-08-28 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |